Investigating the effect of LncRNA DLGAP1-AS2 suppression on chemosensitivity of gastric cancer to chemotherapy.
Azadi SS, Safaralizadeh R, Amini M, Hosseinpour Feizi MA, Abdolzadeh S, Najafi S, Bahojb Mahdavi SZ, Yari A, Narimanzadeh L, Baradaran B, Mokhtarzadeh AA.
Azadi SS, et al.
Naunyn Schmiedebergs Arch Pharmacol. 2024 Oct;397(10):7891-7903. doi: 10.1007/s00210-024-03130-7. Epub 2024 May 15.
Naunyn Schmiedebergs Arch Pharmacol. 2024.
PMID: 38748228
The MTT test indicated the effect of gene therapy with siRNA and oxaliplatin in combination reduced the chemotherapy drug dose to 29.92 M and increased AGS cells' sensitivity to oxaliplatin. Also, the combination therapy caused a significant increase in apoptosis. ...
The MTT test indicated the effect of gene therapy with siRNA and oxaliplatin in combination reduced the chemotherapy drug dose to 29.92 …